Cell viability and MRI performance of highly efficient polyol-coated magnetic nanoparticles
Source abstract
Abstract
This work aimed at determining conditions that would allow us to control the size of the NPs and create a system with characteristics apt for biomedical applications. We describe a comprehensive study on the synthesis and physical characterization of two highly sensitive sets of triethylene glycol (TREG) and polyethylene glycol (PEG)-coated superparamagnetic iron oxide nanoparticles (SPIONs) to be evaluated for use as magnetic resonance (MR) contrast agents. The ferrofluids demonstrated excellent colloidal stability in deionized water at pH 7.0 as indicated by dynamic light scattering (DLS) data. The magnetic relaxivities, r 2, were measured on a 1.5 T clinical MRI instrument. Values in the range from 205 to 257 mM−1 s−1 were obtained, varying proportionally to the SPIONs’ sizes and coating nature. Further in vitro cell viability tests and in vivo biodistribution analyses of the intravenously administered nanoparticles showed that the prepared systems have good biocompatibility and migrate to several organs, mainly the meninges, spleen, and liver. Based on these results, our findings demonstrated the potential utility of these nanosystems as clinical contrast agents for MR imaging.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Ali A, Zafar H, Zia M, Haq I, Rehman A et al (2016) Synthesis, characterization, applications and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl 9:49–6710.2147/NSA.S99986 ↗
2. Ammar S, Helfen A, Jouini N, Fievet F, Roserman I et al (2001) Magnetic properties of ultrafine cobalt ferrite particles synthesized by hydrolysis in a polyol medium. J Mater Chem 11:18610.1039/b003193n ↗
3. Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG et al (2004) Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, alpha-TEA. Cancer Res 64:4263–426910.1158/0008-5472.CAN-03-2327 ↗
4. Angulo-Molina A, Mendez-Rojas MA, Palacios-Hernandez T, Contreras-Lopez OE, Hirata-Flores GA, Flores-Alonso JC, Merino-Contreras S, Valenzuela O, Hernandez J, Reyes-Leyva J (2014) Magnetite nanoparticles functionalized with α-tocopheryl succinate (α-TOS) promote selective cervical cancer cell death. J Nanopart Res 16:252810.1007/s11051-014-2528-6 ↗
5. Arteaga-Cardona F, Rojas-Rojas K, Costo R, Mendez-Rojas MA, Hernando A, de la Presa P (2016a) Improving the magnetic heating by disaggregating nanoparticles. J Alloys Compd 663:63610.1016/j.jallcom.2015.10.285 ↗
6. Arteaga-Cardona F, Santillán-Urquiza E, de la Presa P, Tobón SH, Pal U, Horta-Fraijo P, José-Yacaman M, Lozada-Ramírez JD, Ivkov R, Angulo-Molina A, Méndez-Rojas MA (2016b) Enhanced magnetic properties and MRI performance of bi-magnetic core–shell nanoparticles. RSC Adv 6:7755810.1039/C6RA14265F ↗
7. Beltran-Huarac J, Guinel MJF, Weiner BR, Morell G (2013) Bifunctional Fe3O4/ZnS:Mn composite nanoparticles. Mater Lett 98:10810.1016/j.matlet.2013.02.042 ↗
8. Berry CC (2005) Possible exploitation of magnetic nanoparticle-cell interaction for biomedical applications. J Mater Chem 15:543–54710.1039/B409715G ↗
9. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM et al (2006) Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Investig Radiol 41:313–32410.1097/01.rli.0000197669.80475.dd ↗
10. Branca M, Marciello M, Ciuculescu-Pradines D, Respaud M, Morales MP, Serra R, Casanove MJ, Amiens C (2015) Towards MRI T 2 contrast agents of increased efficiency. J Magn Magn Mater 377:34810.1016/j.jmmm.2014.10.086 ↗
11. Cai W, Wan J (2007) Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J Colloid Interface Sci 305:366–37010.1016/j.jcis.2006.10.023 ↗
12. Clark PR, Chua-Anusorn W, St Pierre TG (2003) Proton transverse relaxation rate (R 2 ) images of liver tissue; mapping local tissue iron concentrations with MRI [corrected]. Magn Reson Med 49:572–57510.1002/mrm.10378 ↗
13. de la Presa P, Luengo Y, Velasco V, Morales MP, Iglesias M, Veintemillas-Verdaguer S, Crespo P, Hernando A (2015) Particle interactions in liquid magnetic colloids by zero field cooled measurements: effects on heating efficiency. J Phys Chem C 119:1102210.1021/jp5115515 ↗
14. de Oliveira CC, Ando RA, Camargo PH (2013) Size-controlled synthesis of silver micro/nanowires as enabled by HCL oxidative etching. Phys Chem Chem Phys 15:1887–189310.1039/C2CP43108D ↗
15. Engelhardt R, Langkowski JH, Fischer R, Nielsen P, Kooijman H et al (1994) Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 12:999–100710.1016/0730-725X(94)91230-T ↗
16. Feldmann C, Jungk HO (2001) Polyol-mediated preparation of nanoscale oxide particles. Angew Chem Int Ed Engl 40:359–36210.1002/1521-3773(20010119)40:2<359::AID-ANIE359>3.0.CO;2-B ↗
17. Fishman A, Acton A, Lee-Ruff E (2004) A simple preparation of PEG-carboxylates by direct oxidation. Synth Commun 34:2309–231210.1081/SCC-120038518 ↗
18. Gao J, Gu H, Xu B (2009) Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 42:1097–110710.1021/ar9000026 ↗
19. Ge YQ, Zhang Y, Gu N et al (2009) Effect of surface charge and agglomerate degree of magnetic iron nanoparticles on KB cellular uptake in vitro. Colloid Surface B 73:294–30110.1016/j.colsurfb.2009.05.031 ↗
20. Ghotbi MY, bin Huessein MZ (2012) Controlled release study of an anti-carcinogenic agent, gallate from the surface of magnetite nanoparticles. J Phys Chem Solids 73:936–94210.1016/j.jpcs.2012.02.031 ↗
21. Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience 3:66–7310.1109/TNB.2003.820277 ↗
22. Hachani R, Lowdell M, Birchall M, Hervault A, Mertz D, Begin-Colin S, Thanh NTK (2016) Polyol synthesis, functionalization and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale 8:327810.1039/C5NR03867G ↗
23. He Q, Wu Z, Huang C (2012) Hollow magnetic nanoparticles: synthesis and applications in biomedicine. J Nanosci Nanotechnol 12:2943–295410.1166/jnn.2012.5679 ↗
24. Hu F, Joshi HM, Dravid VP, Meade TJ (2010) High-performance nanostructured MR contrast probes. Nanoscale 2:1884–189110.1039/c0nr00173b ↗
25. Hu F, Jia Q, Li Y, Gao M (2011) Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T 1 - and T 2 -weighted magnetic resonance imaging. Nanotechnology 22:24560410.1088/0957-4484/22/24/245604 ↗
26. Issa B, Obaidat IM, Albiss BA, Haik Y (2013) Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int J Mol Sci 14:2126610.3390/ijms141121266 ↗
27. Jia Y, Yuan M, Yuan H, Huang X, Sui X et al (2012) Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. Int J Nanomedicine 7:1697–170810.2217/nnm.12.65 ↗
28. Jiang L, Li X, Liu L, Zhang Q (2013) Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res Lett 8:6610.1186/1556-276X-8-66 ↗
29. Joseyphus RJ, Shinoda K, Kodama D, Jeyadevan B (2010) Size controlled Fe nanoparticles through polyol process and their magnetic properties. Mater Chem Phys 123:48710.1016/j.matchemphys.2010.05.001 ↗
30. Kim DH, Lee SH, Im KH, Kim KN, Kim KM et al (2006a) Surface-modified magnetite nanoparticles for hyperthermia: preparation, characterization, and cytotoxicity studies. Curr Appl Phys 6. Supplement 1:e242–e246
31. Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ et al (2006b) Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89:338–34710.1093/toxsci/kfj027 ↗
32. Kong SD, Lee J, Ramachandran S, Eliceiri BP, Shubayev VI et al (2012) Magnetic targeting of nanoparticles across the intact blood-brain barrier. J Control Release 164:49–5710.1016/j.jconrel.2012.09.021 ↗
33. Kwon JT, Hwang SK, Jin H, Kim DS, Minai-Tehrani A et al (2008) Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 50:1–610.1539/joh.50.1 ↗
34. Lind K, Kresse M, Debus NP, Muller RH (2002) A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J Drug Target 10:221–23010.1080/10611860290022651 ↗
35. Liu G, Gao J, Ai H, Chen X (2013) Applications and potential toxicity of magnetic iron oxide nanoparticles. Small 9:1533–154510.1002/smll.201201531 ↗
36. Ma Y, Zheng Y, Liu K, Tian G, Tian Y et al (2010) Nanoparticles of poly(Lactide-Co-Glycolide)-d-α-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment. Nanoscale Res Lett 5:1161–116910.1007/s11671-010-9620-3 ↗
37. Masala O, Seshadri R (2005) Magnetic properties of capped, soluble MnFe2O4 nanoparticles. Chem Phys Lett 402:16010.1016/j.cplett.2004.12.032 ↗
38. Merbach A, Helm L, Toth E (eds) (2001) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, Chichester
39. Miguel-Sancho N, Bomati-Miguel O, Colom G, Salvador JP, Marco MP, Santamaria J (2011) Development of stable, water-dispersible, and biofunctionalizable superparamagnetic iron oxide nanoparticles. Chem Mater 23:279510.1021/cm1036452 ↗
40. Mondini S, Cenedese S, Marioni G, Molteni G, Santo N et al (2008) One-step synthesis and functionalization of hydroxyl-decorated magnetite nanoparticles. J Colloid Interface Sci 322:17310.1016/j.jcis.2008.03.008 ↗
41. Mornet S, Vasseur S, Grasset F, Duquet E (2004) Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14:2161–217510.1039/b402025a ↗
42. National Research Council (2011) Guide for the Care and Use of Laboratory Animals 8th edn. National Academies Press, Washington, DC
43. OsiriX (2004) An open source software for navigation in multidimensional DICOM images. J Digit Imaging 17:205–21610.1007/s10278-004-1014-6 ↗
44. Panagiotopoulos N, Duschka RL, Ahlborg M, Bringout G, Debbeler C et al (2015) Magnetic particle imaging: current developments and future directions. Int J Nanomedicine 10:3097–311410.2147/IJN.S70488 ↗
45. Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:R16710.1088/0022-3727/36/13/201 ↗
46. Papakonstantinou OG, Maris TG, Kostaridou V, Gouliamos AD, Koutoulas GK et al (1995) Assessment of liver iron overload by T 2 -quantitative magnetic resonance imaging: correlation of T 2 -QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 13:967–97710.1016/0730-725X(95)00041-E ↗
47. Piñeiro-Redondo Y, Bañobre-López M, Pardiñas-Blanco I, Goya G, López-Quintela MA, Rivas J (2011) The influence of colloidal parameters on the specific power absorption of PAA-coated magnetite nanoparticles. Nanoscale Res Lett 6:38310.1186/1556-276X-6-383 ↗
48. Pisciotti MLM, Lima E, Vasquez Mansilla M, Tognoli VE, Troiani HE, Pasa AA, Creczynski-Pasa TB, Silva AH, Gurman P, Colombo L, Goya GF, Lamagna A, Zysler RD (2016) In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting. J Biomed Mat Res B Appl Biomat 102:860–86810.1002/jbm.b.33068 ↗
49. Rohani Moghadam M, Haji Shabani AM, Dadfarnia S (2015) Simultaneous spectrophotometric determination of Fe(III) and Al(III) using orthogonal signal correction-partial least squares calibration method after solidified floating organic drop microextraction. Spectrochim Acta A Mol Biomol Spectrosc 135:929–93410.1016/j.saa.2014.08.007 ↗
50. Rojas-Perez A, Diaz-Diestra D, Frias-Flores CB, Beltran-Huarac J, Das KC, Weiner BR, Morell G, Diaz-Vazquez LM (2015) Catalytic effect of ultrananocrystalline Fe3O4 on algal bio-crude production via HTL process. Nanoscale 7:1766410.1039/C5NR04404A ↗
51. Roper WL (1988) Shaping the future of American medicine. Ala J Med Sci 25:470–474
52. Santillán-Urquiza E, Arteaga-Cardona F, Hernandez-Herman E, Pacheco-García PF, González-Rodríguez R, Coffer JL, Mendoza-Alvarez ME, Vélez-Ruiz JF, Méndez-Rojas MA (2015) Inulin as a novel biocompatible coating: evaluation of surface affinities toward CaHPO4, α-Fe2O3, ZnO, CaHPO4@ZnO and α-Fe2O3@ZnO nanoparticles. J Colloid Interface Sci 460:33910.1016/j.jcis.2015.08.057 ↗
53. Sun P, Hui C, Azim Khan R, Du J, Zhang Q et al (2015) Efficient removal of crystal violet using Fe3O4-coated biochar: the role of the Fe3O4 nanoparticles and modeling study their adsorption behavior. Sci Rep 5:1263810.1038/srep12638 ↗
54. Wahajuddin, Sumit A (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 7:344510.2147/IJN.S30320 ↗
55. Wang YX (2011) Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 1:35–40
56. Wang LM, Song C, Jin J (1982) Spectrophotometric determination of iron with 1,10-phenanthroline in the presence of copper. Microchim Acta 78:115–12410.1007/BF01206697 ↗
57. Wang Z, Zhu H, Wang X, Yang F, Yang X (2009) One-pot green synthesis of biocompatible arginine-stabilized magnetic nanoparticles. Nanotechnology 20:46560610.1088/0957-4484/20/46/465606 ↗
58. Wei C, Wan J (2007) Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J Colloid Interface Sci 305:36610.1016/j.jcis.2006.10.023 ↗
59. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC et al (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Rentgenol 152:16710.2214/ajr.152.1.167 ↗
60. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH et al (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489–49310.1148/radiology.175.2.2326474 ↗
61. Witter R, Roming M, Feldmann C, Ulrich AS (2013) Multilayered core-shell structure of polyol-stabilized calcium fluoride nanoparticles characterized by NMR. J Colloid Interface Sci 390:250–25710.1016/j.jcis.2012.09.001 ↗
62. Wu W, He Q, Jiang C (2008) Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett 3:397–41510.1007/s11671-008-9174-9 ↗
63. Xue S, Zhang C, Yi Y, Zhang L, Dengfeng C, Zhang J, Shi H, Zhang Y (2015) 99mTc-labeled iron oxide nanoparticles for dual-contrast (T 1 /T 2 ) magnetic resonance and dual-modality imaging of tumor angiogenesis. J Biomed Nanotech 11:102710.1166/jbn.2015.2023 ↗
64. Yallapu MM, Foy SP, Jain TK, Labhasetwar V (2010) PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res 27:2283–229510.1007/s11095-010-0260-1 ↗
65. Yang K, Feng L, Hong H, Cai W, Liu Z (2013) Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat Protoc 8:2392–240310.1038/nprot.2013.146 ↗
66. Zhang DH, Li GD, Li JX, Chen JS (2008) One-pot synthesis of Ag-Fe3O4 nanocomposite: a magnetically recyclable and efficient catalyst for epoxidation of styrene. Chem Commun 29:3414–341610.1039/b805737k ↗
67. Zhang L, Dong WF, Sun HB (2013) Multifunctional superparamagnetic iron oxide nanoparticles: design, synthesis and biomedical photonic applications. Nanoscale 5:766410.1039/c3nr01616a ↗
68. Zhu L, Torchilin VP (2013) Stimulus-responsive nanopreparations for tumor targeting. Integr Biol 5:96–10710.1039/C2IB20135F ↗